Work

P2.12-06 Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib

Year: 2023

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.641

Authors: N.D. Robinson, P. Zhan, B. Udelsman, D.J. Boffa, S.B. Goldberg

Institution: Yale University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388045862

FWCI:

Cites:

Cited by:

Related to: 10